Pilot Study of Genotypic Analysis
NCT00421837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6
Last updated 2013-08-16
Summary
Influenza (the flu) is a leading cause of respiratory (breathing) illness that leads to sickness and death during the winter months. A better understanding of why certain people get the flu or get sicker with the flu than other people is important for developing improved vaccines and treatments. This study will look at the genetic makeup (determines each person's specific characteristics and traits) of 50 patients, older than 50, who were hospitalized with flu at Vanderbilt University during the 2006-2007 flu season. Their genetic makeup will be compared with the genetic makeup of 50 people who are not related but were in close daily contact with the flu patient and were not infected with flu virus. The study staff will collect a blood sample (contains genetic material) from each participant (flu patients and their contacts) for comparison. Flu patients will have completed a health survey as part of the previous study, and their contacts will complete a shorter version of this survey.
Conditions
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2008-12-31
- Completion
- 2008-12-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.
NCT01262079 ·Status: COMPLETED
-
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents
NCT02352389 ·Status: COMPLETED
-
2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control Strategies
NCT01270685 ·Status: WITHDRAWN
-
A Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in Mexico
NCT02378090 ·Status: COMPLETED
-
Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects
NCT00918268 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults
NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
NCT00630331 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic and Environmental Factors in the Response to Influenza Vaccination
NCT03088904 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
NCT00984451 ·Status: COMPLETED
-
Reverse Genetic H9N2 Influenza Vaccine Study in Adults
NCT01320696 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
NCT01422512 ·Status: COMPLETED ·Phase: PHASE3
-
Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
NCT02154061 ·Status: COMPLETED ·Phase: NA
-
Influenza Virus - A Multicenter Registry
NCT01256255 ·Status: COMPLETED
-
Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation
NCT00718146 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)
NCT00783926 ·Status: COMPLETED ·Phase: PHASE1
-
Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine
NCT01063088 ·Status: COMPLETED ·Phase: PHASE3
-
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
NCT03599739 ·Status: COMPLETED
-
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed
NCT05422326 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
NCT00800605 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation
NCT00946179 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
NCT02385123 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
NCT02019732 ·Status: COMPLETED
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults
NCT00264576 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)
NCT00289510 ·Status: COMPLETED ·Phase: PHASE1/PHASE2